S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.85 (+1.79%)
AAPL   143.23 (+4.10%)
MSFT   260.96 (+3.33%)
FB   196.30 (+1.43%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,153.50 (+0.08%)
TSLA   675.00 (+1.67%)
NVDA   169.60 (+1.59%)
BABA   87.52 (+0.84%)
NIO   15.93 (-3.10%)
AMD   95.39 (+2.02%)
CGC   5.20 (-5.80%)
MU   69.59 (+1.00%)
T   20.76 (+1.76%)
GE   75.44 (+0.25%)
F   12.84 (+2.72%)
DIS   105.85 (+3.35%)
AMC   11.69 (-2.83%)
PFE   52.86 (+0.74%)
PYPL   81.19 (+0.81%)
NFLX   187.98 (+0.87%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.85 (+1.79%)
AAPL   143.23 (+4.10%)
MSFT   260.96 (+3.33%)
FB   196.30 (+1.43%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,153.50 (+0.08%)
TSLA   675.00 (+1.67%)
NVDA   169.60 (+1.59%)
BABA   87.52 (+0.84%)
NIO   15.93 (-3.10%)
AMD   95.39 (+2.02%)
CGC   5.20 (-5.80%)
MU   69.59 (+1.00%)
T   20.76 (+1.76%)
GE   75.44 (+0.25%)
F   12.84 (+2.72%)
DIS   105.85 (+3.35%)
AMC   11.69 (-2.83%)
PFE   52.86 (+0.74%)
PYPL   81.19 (+0.81%)
NFLX   187.98 (+0.87%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.85 (+1.79%)
AAPL   143.23 (+4.10%)
MSFT   260.96 (+3.33%)
FB   196.30 (+1.43%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,153.50 (+0.08%)
TSLA   675.00 (+1.67%)
NVDA   169.60 (+1.59%)
BABA   87.52 (+0.84%)
NIO   15.93 (-3.10%)
AMD   95.39 (+2.02%)
CGC   5.20 (-5.80%)
MU   69.59 (+1.00%)
T   20.76 (+1.76%)
GE   75.44 (+0.25%)
F   12.84 (+2.72%)
DIS   105.85 (+3.35%)
AMC   11.69 (-2.83%)
PFE   52.86 (+0.74%)
PYPL   81.19 (+0.81%)
NFLX   187.98 (+0.87%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.85 (+1.79%)
AAPL   143.23 (+4.10%)
MSFT   260.96 (+3.33%)
FB   196.30 (+1.43%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,153.50 (+0.08%)
TSLA   675.00 (+1.67%)
NVDA   169.60 (+1.59%)
BABA   87.52 (+0.84%)
NIO   15.93 (-3.10%)
AMD   95.39 (+2.02%)
CGC   5.20 (-5.80%)
MU   69.59 (+1.00%)
T   20.76 (+1.76%)
GE   75.44 (+0.25%)
F   12.84 (+2.72%)
DIS   105.85 (+3.35%)
AMC   11.69 (-2.83%)
PFE   52.86 (+0.74%)
PYPL   81.19 (+0.81%)
NFLX   187.98 (+0.87%)
NASDAQ:DRTS

Alpha Tau Medical News Headlines

$5.60
+0.19 (+3.51%)
(As of 05/23/2022 03:59 PM ET)
Add
Compare
Today's Range
$5.11
▼
$6.35
50-Day Range
$5.19
▼
$15.30
52-Week Range
$4.68
▼
$20.65
Volume
2,627 shs
Average Volume
607,331 shs
Market Capitalization
$372.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.94
Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Alpha Tau Medical Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DRTS
News Sentiment
▼
0.00

0.30
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DRTS Articles
This Week
▼
1

2
▲
DRTS Articles
Average Week



Alpha Tau Medical (NASDAQ:DRTS) News Headlines Today

SourceHeadline
finance.yahoo.com logoFirst Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer Trial
finance.yahoo.com - May 23 at 10:21 AM
investing.com logoAlpha Tau Medical Ltd (DRTS)
investing.com - May 14 at 11:35 PM
seekingalpha.com logoMedical device maker Alpha Tau stock rallies 17% following days of decline
seekingalpha.com - May 12 at 3:46 PM
MarketBeat logoAlpha Tau Medical (NASDAQ:DRTS) Stock Rating Upgraded by Zacks Investment Research
americanbankingnews.com - May 7 at 1:58 AM
realmoney.thestreet.com logoAlpha Tau Medical Ltd
realmoney.thestreet.com - April 30 at 10:48 PM
MarketBeat logoZacks Investment Research Downgrades Alpha Tau Medical (NASDAQ:DRTS) to Sell
americanbankingnews.com - April 30 at 3:56 AM
seekingalpha.com logoIsraeli medtech Alpha Tau stock slides 12% after rallying 20% in prior session
seekingalpha.com - April 22 at 6:46 PM
seekingalpha.com logoAlpha Tau: Treating Cancer With Precision Alpha Radiation
seekingalpha.com - April 12 at 4:08 PM
finance.yahoo.com logoCould The Alpha Tau Medical Ltd. (NASDAQ:DRTS) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - April 12 at 11:07 AM
seekingalpha.com logoAlpha Tau Medical gains as Citi initiates coverage with a Buy rating
seekingalpha.com - April 4 at 4:19 PM
seekingalpha.com logoAlpha Tau Medical GAAP EPS of -$0.67
seekingalpha.com - March 29 at 8:27 PM
finance.yahoo.com logoAlpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - March 28 at 6:59 PM
nasdaq.com logoAlpha Tau Medical Ltd. Rings the Nasdaq Stock Market Opening Bell
nasdaq.com - March 25 at 7:01 PM
fool.com logoWhy Alpha Tau Medical Ltd. Stock Soared 42% on Wednesday
fool.com - March 23 at 6:47 PM
finance.yahoo.com logoAlpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors
finance.yahoo.com - March 21 at 4:40 PM
Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.